Our attempt to control bias by recruiting individuals unfamiliar to the moderator was not wholly achieved (11/16, 69%) due to the moderator’s clinical role within service delivery. All participants were inner city inhabitants, mainly of white ethnicity and with moderate COPD, which limits the study’s generalisability somewhat. Also, the current study only reflects views of patients who were able to access pulmonary rehabilitation locations independently. Since inadequate transport is associated with some patients’ ability to participate in pulmonary rehabilitation (Keating et al 2011), the selection bias introduced by our inclusion criteria is a limitation. These data highlight the

difficulties experienced by people with COPD in maintaining an active lifestyle and suggest that confidence is an important determinant SCR7 supplier of physical activity participation in COPD. Health services should look to work in collaboration with local authorities and voluntary organisations to increase opportunities for people with COPD to be physically active, recognising the importance of continued peer and professional support. Ethics:

The Faculty of Health Research Ethics and Governance Committee, University of Brighton; Lewisham Local Research Ethics Committee, University Hospital Lewisham; and the Research and Development Committee AP24534 of King’s College Hospital NHS Foundation Trust approved this study. All participants gave written informed consent prior to data collection. eAddenda: Appendix 1 available at jop.physiotherapy.asn.au Lynda Haggis and Rebecca Hopwood from the Lambeth and Southwark Pulmonary Rehabilitation Team, King’s College Hospital NHS Foundation Trust. “
“Summary of: Scholtes VA et al (2012) Effectiveness of functional progressive resistance exercise training on walking ability in children with cerebral palsy: a randomized controlled trial. Res Dev Disabil 33: 181–188.

[Prepared by Nora Shields, CAP Editor.] Question: Does functional progressive resistance exercise (PRE) GPX6 improve walking ability and participation in school-aged children with cerebral palsy (CP)? Design: Randomised, controlled trial with concealed allocation and blinded outcome assessment. Setting: Three special schools for children with physical disability in the Netherlands. Participants: Ambulatory children (Gross Motor Function Classification System 1–3) with spastic unilateral or bilateral cerebral palsy aged 6–13 years. Botulinum toxin injections in the previous three months or orthopaedic surgery in the previous six months were exclusion criteria. Randomisation of 51 participants allocated 26 to the functional PRE group and 25 to a usual care group. Interventions: The intervention group participated in a 12-week functional PRE program, three times a week for 60 inhibitors minutes in groups of 4 or 5.